ÀÏ ½Ã : 2006³â 10¿ù 27ÀÏ(±Ý) 09:00~12:00
 Æò Á¡ : ºÐ°úº° 3ÆòÁ¡
ºÐ°ú½Ã°£±³À°ÁÖÁ¦¼Ò¼Ó°­»ç¸í
³»ºÐºñ
´ë »ç
Update on Osteoporosis <ÁÂÀå: À±Çö±¸, º¯µ¿¿ø>
09:00~09:40 Assessment of fracture risk °æÈñÀÇ´ë ±è´öÀ±
09:40~10:20 Nutritional supplementation for osteoporosis
(calcium and vitamin D)
¿¬¼¼ÀÇ´ë ÀÌÀ¯¹Ì
10:40~11:20 Long term efficacy and safety of anti-resorptive therapy °æÈñÀÇ´ë Á¤È£¿¬
11:20~12:00 Pros and cons of vertebroplasty and/or kyphoplasty for vertebral fractrue À»ÁöÀÇ´ë ±èȯÁ¤
Ç÷ ¾×
Á¾ ¾ç
Consultative Hematology <ÁÂÀå: ¹Ú¼±¾ç>
09:00~09:20 Anemia and erythrocytosis in surgical patients ´ë±¸ÆÄƼ¸¶º´¿ø ÀÌÁ¤¸²
09:20~09:40 Management of bleeding disorders in surgical patients ÇѸ²ÀÇ´ë ±èÈ¿Á¤
09:40~10:00 Prevention and treatment of thrombotic disorders in surgical patients ºÎ»êÀÇ´ë ½ÅÈ£Áø
10:00~10:20 Hematologic problems in pregnancy ´ë±¸°¡Å縯ÀÇ´ë ·ùÇå¸ð
Consultative Oncology <ÁÂÀå: ³ëÀç°æ>
10:40~11:00 Special considerations in surgery of cancer patients Àü³²ÀÇ´ë Á¤ÀÍÁÖ
11:00~11:20 Resection of metastatic disease ÃæºÏÀÇ´ë À̱âÇü
11:20~11:40 Management of cancer-associated complications ÇѾçÀÇ´ë ÃÖÁ¤Çý
11:40~12:00 Thrombotic complications in cancer patients ¼­¿ïÀÇ´ë ¹æ¼ö¹Ì
°¨ ¿° ¼ºÀÎÀÇ ¿¹¹æÁ¢Á¾
09:00~09:40 ÀÎÇ÷翣ÀÚ °í·ÁÀÇ´ë Á¤ÈñÁø
09:40~10:20 Æó·Å¾Ë±Õ ¼º±Õ°üÀÇ´ë ¿À¿ø¼·
10:40~11:20 ¼ö¸·¾Ë±Õ °æÈñÀÇ´ë ÀÌ»ó¿À
11:20~12:00 ÆÄ»ódz/µðÇÁÅ׸®¾Æ °¡Å縯ÀÇ´ë ÃÖÁ¤Çö
¾Ë ·¹
¸£ ±â
Recent Update of Allergy
09:00~09:30 Hypereosinophilia ȯÀÚÀÇ Á¢±Ù °¡ÃµÀÇ´ë ÀÌ»óÇ¥
09:30~10:00 Pharmacogenetics in aspirin allergy ¼øõÇâÀÇ´ë Àå¾È¼ö
10:00~10:30 ¸¸¼º±âħ ¼­¿ïÀÇ´ë ÀåÀ±¼®
11:00~11:30 Asthma¿¡¼­ÀÇ VEGF ÀüºÏÀÇ´ë ÀÌ¿ëö
11:30~12:00 ¾Ë·¹¸£±â Áúȯ¿¡¼­ÀÇ ¸é¿ªÄ¡·áÀÇ ¿øÄ¢ ¿¬¼¼ÀÇ´ë ¹ÚÁß¿ø
·ù ¸¶
Ƽ ½º
Àü½ÅÈ«¹Ý¼º·çǪ½ºÀÇ ÃÖ½ÅÁö°ß
09:00~09:30 Genetics of SLE °í·ÁÀÇ´ë ÀÌ¿µÈ£
09:30~10:00 Autoantibodies in SLE À»ÁöÀÇ´ë ½É½Âö
10:00~10:30 Premature atherosclerotic disease in SLE Æ÷õÁß¹®ÀÇ´ë ÃÖÁøÁ¤
10:50~11:25 Infections and SLE ¾ÆÁÖÀÇ´ë ¼­Ã¢Èñ
11:25~11:55 Newer therapeutic approaches for SLE ÀÌÈ­ÀÇ´ë ÀÌÁö¼ö